Targeting miR-199a reduces fibrosis in hypertrophic cardiomyopathy

Bibliographic Details
Main Authors: Stanislovas S. Jankauskas, Fahimeh Varzideh, Urna Kansakar, Gaetano Santulli
Format: Article
Language:English
Published: Elsevier 2024-03-01
Series:Journal of Molecular and Cellular Cardiology Plus
Online Access:http://www.sciencedirect.com/science/article/pii/S2772976123000272
_version_ 1827315467569594368
author Stanislovas S. Jankauskas
Fahimeh Varzideh
Urna Kansakar
Gaetano Santulli
author_facet Stanislovas S. Jankauskas
Fahimeh Varzideh
Urna Kansakar
Gaetano Santulli
author_sort Stanislovas S. Jankauskas
collection DOAJ
first_indexed 2024-03-08T14:34:50Z
format Article
id doaj.art-2e74077875ec412b8b22dd0bf310c153
institution Directory Open Access Journal
issn 2772-9761
language English
last_indexed 2024-04-24T22:56:49Z
publishDate 2024-03-01
publisher Elsevier
record_format Article
series Journal of Molecular and Cellular Cardiology Plus
spelling doaj.art-2e74077875ec412b8b22dd0bf310c1532024-03-18T04:34:55ZengElsevierJournal of Molecular and Cellular Cardiology Plus2772-97612024-03-017100057Targeting miR-199a reduces fibrosis in hypertrophic cardiomyopathyStanislovas S. Jankauskas0Fahimeh Varzideh1Urna Kansakar2Gaetano Santulli3Department of Medicine, Division of Cardiology, Wilf Family Cardiovascular Research Institute, Einstein Institute for Neuroimmunology and Inflammation (INI), Albert Einstein College of Medicine, Montefiore University Hospital, New York, NY 10461, USADepartment of Medicine, Division of Cardiology, Wilf Family Cardiovascular Research Institute, Einstein Institute for Neuroimmunology and Inflammation (INI), Albert Einstein College of Medicine, Montefiore University Hospital, New York, NY 10461, USADepartment of Molecular Pharmacology, Einstein-Mount Sinai Diabetes Research Center (ES-DRC), Fleischer Institute for Diabetes and Metabolism (FIDAM), Einstein Institute for Aging Research, Albert Einstein College of Medicine, Montefiore University Hospital, New York, NY 10461, USADepartment of Medicine, Division of Cardiology, Wilf Family Cardiovascular Research Institute, Einstein Institute for Neuroimmunology and Inflammation (INI), Albert Einstein College of Medicine, Montefiore University Hospital, New York, NY 10461, USA; Department of Molecular Pharmacology, Einstein-Mount Sinai Diabetes Research Center (ES-DRC), Fleischer Institute for Diabetes and Metabolism (FIDAM), Einstein Institute for Aging Research, Albert Einstein College of Medicine, Montefiore University Hospital, New York, NY 10461, USA; Corresponding author at: 1300 Morris Park Avenue, 10461 New York, NY, USA.http://www.sciencedirect.com/science/article/pii/S2772976123000272
spellingShingle Stanislovas S. Jankauskas
Fahimeh Varzideh
Urna Kansakar
Gaetano Santulli
Targeting miR-199a reduces fibrosis in hypertrophic cardiomyopathy
Journal of Molecular and Cellular Cardiology Plus
title Targeting miR-199a reduces fibrosis in hypertrophic cardiomyopathy
title_full Targeting miR-199a reduces fibrosis in hypertrophic cardiomyopathy
title_fullStr Targeting miR-199a reduces fibrosis in hypertrophic cardiomyopathy
title_full_unstemmed Targeting miR-199a reduces fibrosis in hypertrophic cardiomyopathy
title_short Targeting miR-199a reduces fibrosis in hypertrophic cardiomyopathy
title_sort targeting mir 199a reduces fibrosis in hypertrophic cardiomyopathy
url http://www.sciencedirect.com/science/article/pii/S2772976123000272
work_keys_str_mv AT stanislovassjankauskas targetingmir199areducesfibrosisinhypertrophiccardiomyopathy
AT fahimehvarzideh targetingmir199areducesfibrosisinhypertrophiccardiomyopathy
AT urnakansakar targetingmir199areducesfibrosisinhypertrophiccardiomyopathy
AT gaetanosantulli targetingmir199areducesfibrosisinhypertrophiccardiomyopathy